NPPA Cuts Prices of 137 Anti-Cancer Drugs

The National Pharmaceutical Pricing Authority (NPPA) has introduced a cap on trade margins for 137 anti-cancer medicines, bringing down their prices to make cancer treatment more affordable. The revised rates have come into effect from today.

So far, 76 pharmaceutical companies have submitted revised prices for 1,225 formulations covering 121 drugs. Of these, 1,031 formulations have witnessed price reductions. Around 600 brands have recorded cuts of more than 50%, with the highest reduction reaching 96.45%.

The government estimates that the move will help consumers save approximately ₹3,502.31 crore annually. The trade margin regulation will also apply to 10–15 identified cancer drugs that are yet to be launched in India, once they enter the market.

The initiative aims to improve access to essential cancer medicines and reduce the financial burden on patients.